3D Bioprinting: The Roller Coaster Ride to Commercialization.
3D Bioprinting: The Roller Coaster Ride to Commercialization.
复制标题
3D生物打印：商业化进程的跌宕之路
DOI：
10.18063/ijb.v6i3.301
复制
发表时间：
2020
影响因子：
8.4
通讯作者：
Khesuani YD
中科院分区：
文献类型：
--
作者：
Elemoso A;Shalunov G;Balakhovsky YM;Ostrovskiy AY;Khesuani YD
三维（3D）生物打印作为一种技术，自2003年以来一直在研究和应用。它实际上是“3D生物打印”这一总称下的多种技术（喷墨、挤出、激光、磁性生物打印等）。该技术的多功能性使其能够广泛应用于多种领域；但经过近20年的研究，商业化应用的案例仍然有限。本文讨论了 3D 生物打印在再生医学、药物发现和食品工业中的潜力，以及在上述领域甚至时尚领域创造商业化产品和服务的公司的现有案例，包括他们的上市路线和收到的融资。我们还解决了在正在研究的技术的每个领域内创建 3D 生物打印实际应用的主要障碍。
Three-dimensional (3D) bioprinting as a technology is being researched and applied since 2003. It is actually several technologies (inkjet, extrusion, laser, magnetic bioprinting, etc.) under an umbrella term “3D bioprinting.” The versatility of this technology allows widespread applications in several; however, after almost 20 years of research, there is still a limited number of cases of commercialized applications. This article discusses the potential for 3D bioprinting in regenerative medicine, drug discovery, and food industry, as well as the existing cases of companies that create commercialized products and services in the aforementioned areas and even in fashion, including their go-to-market route and financing received. We also address the main barriers to creating practical applications of 3D bioprinting within each sphere the technology that is being studied for.
登录
查看更多内容
影响因子：
4.6
作者：
Horváth L;Umehara Y;Jud C;Blank F;Petri-Fink A;Rothen-Rutishauser B
通讯作者：
Rothen-Rutishauser B
影响因子：
44.1
作者：
Friend, James;Yeo, Leslie Y.
通讯作者：
Yeo, Leslie Y.
影响因子：
3.7
作者：
Di Prima, Matthew;Coburn, James;Ricles, Laura
通讯作者：
Ricles, Laura
影响因子：
4.6
作者：
Campbell, Phil G.;Weiss, Lee E.
通讯作者：
Weiss, Lee E.
影响因子：
9
作者：
Keriquel, Virginie;Guillemot, Fabien;Catros, Sylvain
通讯作者：
Catros, Sylvain